Vical Provides Company Update at Biocom's Global Life Science Partnering Conference
February 24, 2017 15:00 ET
|
Vical Incorporated
SAN DIEGO, Feb. 24, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 2:15...
Vical Provides Company Update at BIO CEO and Investor Conference
February 07, 2017 06:30 ET
|
Vical Incorporated
SAN DIEGO, Feb. 07, 2017 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook at 1:00...
Vical Reports Third Quarter 2016 Financial Results
November 03, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Nov. 03, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and nine months ended September 30, 2016. Net loss for the third...
Vical Announces News Release and Conference Call Schedule for Third Quarter 2016 Financial Results
October 27, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Oct. 27, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended September 30, 2016, before...
Vical Announces Initiation of a Phase 2 Trial of Its HSV-2 Therapeutic DNA Vaccine for Genital Herpes
September 26, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Sept. 26, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced today the initiation of a Phase 2 trial of the company’s Vaxfectin™-formulated, bivalent, therapeutic DNA...
Vical and Astellas Announce Topline Results from a Phase 2 Study of Investigational Cytomegalovirus (CMV) Vaccine (ASP0113) in Kidney Transplant Patients
September 19, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO and TOKYO, Sept. 19, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) and Astellas Pharma Inc. (TOKYO:4503) today announced topline results from a randomized, double-blind,...
Vical to Present at the 18th Annual Rodman & Renshaw Global Investment Conference
September 02, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Sept. 02, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will provide an overview of its technologies, development programs, and outlook on...
Vical Reports Second Quarter 2016 Financial Results
August 09, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Aug. 09, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today reported financial results for the three and six months ended June 30, 2016. Net loss for the second quarter of...
Vical Announces News Release and Conference Call Schedule for Second Quarter 2016 Financial Results
August 02, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Aug. 02, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) today announced that the company will report financial results for the three months ended June 30, 2016, before the...
Vical Announces $7.8 Million Equity Investment by Partner, AnGes MG
August 01, 2016 06:30 ET
|
Vical Incorporated
SAN DIEGO, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Vical Incorporated (Nasdaq:VICL) announced an agreement by AnGes, MG, Vical’s long-time partner and an existing shareholder, to purchase approximately...